2,3-dimethyl-5-(4-chlorophenyl)furan | 72946-32-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,3-dimethyl-5-(4-chlorophenyl)furan
• 英文别名: 5-(4-chlorophenyl)-2,3-dimethylfuran；5-(4-chloro-phenyl)-2,3-dimethyl-furan；2.3-Dimethyl-5-(p-chlorphenyl)-furan
• CAS: 72946-32-8
• 化学式: C₁₂H₁₁ClO
• 分子量: 206.672
• InChiKey: APSCUGNHNIZYMR-UHFFFAOYSA-N

物化性质

• 熔点：
  87-89 °C
• 沸点：
  274.1±35.0 °C(Predicted)
• 密度：
  1.135±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  13.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-(4-chlorophenyl)-2-(2-hydroxy-2-methylcyclopropyl)ethan-1-one 在 对甲苯磺酸 作用下， 以 甲醇 为溶剂， 反应 5.0h， 以87%的产率得到2,3-dimethyl-5-(4-chlorophenyl)furan
  参考文献：
  名称：

  Ring-opening of tertiary cyclopropanols derived from β-diketones

  摘要：

  The ring-opening reaction of 1,2-di substituted cyclopropanols, prepared from beta-diketones, mediated by Cu(NO3)(2), p-TsOH, and NaOH is reported. The Cu(II)-mediated ring-opening of cyclopropanols gave alpha-methylene-gamma-diketones in good yields. The reaction took place at the less substituted carbon of the cyclopropanols, involving mild conditions and a simple procedure. The reaction induced by p-TsOH in CH2O2 afforded alpha-methyl-gamma-diketones as the major product with minor amounts of 8-diketones. The 2,3,5-tri substituted furans were obtained in high yields when the ring-opening reaction was mediated by p-TsOH in methanol under reflux conditions. In the presence of sodium hydroxide the reaction proceeded smoothly in preference to the formation of beta-diketones, particularly for substrates with an aromatic group on the cyclopropane. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2006.05.064

文献信息

• 酮与alpha氯代酮一步反应合成呋喃类化合物的方法
  申请人：重庆医科大学

  公开号：CN113861137B

  公开（公告）日：2023-08-15

  本发明提供一种以alpha‑氯代酮和甲基酮或环酮为原料，在略微过量的钛酸四异丙酯作用下，无溶剂条件下一步反应制备多取代呋喃化合物的方法。即在惰性气体保护下，将甲基酮或环酮、α‑氯代酮和对甲苯磺酸的反应混合物搅拌加热升温后，加入钛酸四异丙酯进行反应，反应结束后再将所得反应混合物进行分离提纯，得到多取代呋喃化合物。本发明所述的合成方法，原料易得，成本低廉，操作简单易控，无需溶剂，有良好的底物普适性和官能团兼容性，适宜于工业化大生产。
• Titanium-Mediated Domino Cross-Coupling/Cyclodehydration and Aldol-Addition/Cyclocondensation: Concise and Regioselective Synthesis of Polysubstituted and Fused Furans
  作者：Lu Ren、Juan Luo、Linbo Tan、Qiang Tang

  DOI：10.1021/acs.joc.1c02894

  日期：2022.3.4

  Titanium enolates, in situ-generated from readily available ketones and titanium tetraisopropoxide, undergo domino cross-coupling/cyclodehydration or domino Aldol-addition/cyclocondensation with α-chloroketones to provide synthetically valuable furan derivatives. The domino process tolerates a variety of cyclic and acyclic ketones and chloroketones, producing polysubstituted furans and bi-, tri-, and

  由容易获得的酮和四异丙醇钛原位生成的钛烯醇化物与α-氯酮进行多米诺交叉偶联/环脱水或多米诺醛醇加成/环缩合，以提供具有合成价值的呋喃衍生物。多米诺工艺耐受多种环状和非环状酮和氯酮，产生多取代呋喃和双环、三环和四环稠合呋喃。
• Compounds with nematicidal activity
  申请人：Bayer CropScience AG

  公开号：EP2606727A1

  公开（公告）日：2013-06-26

  The present invention relates to the use of predominantly known pyridyl carboxamide derivatives as nematicides, compositions containing such compounds and methods for the control of nematodes.

  本发明涉及主要已知的吡啶基羧酰胺衍生物作为线虫杀剂的用途，含有这类化合物的组合物以及用于控制线虫的方法。
• Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
  申请人：Hendrix A. James

  公开号：US20070142351A1

  公开（公告）日：2007-06-21

  The invention relates to heterocyclic substituted amide derivatives that display selective binding to dopamine D 3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D 3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine D 3 receptors.

  本发明涉及杂环取代酰胺衍生物，其显示对多巴胺D3受体的选择性结合。另一方面，本发明涉及一种治疗中枢神经系统疾病的方法，该疾病与需要该治疗的患者的多巴胺D3受体活性有关，包括向受试者投予所述化合物的治疗有效量以缓解该疾病。这些化合物可以治疗的中枢神经系统疾病包括精神病性障碍、物质依赖、物质滥用、运动障碍（如帕金森病、帕金森综合征、神经阻滞剂引起的迟发性运动障碍、吉尔·德·拉·图雷特综合征和亨廷顿病）、痴呆、焦虑症、睡眠障碍、昼夜节律障碍和情绪障碍。本发明还涉及制备上述化合物的过程，以及将这些化合物用作多巴胺D3受体成像剂的方法。
• FABRITSY A.; VIXERT S., ZH. OBSHCH. XIMII, 1979, 49, HO 11, 2499-2504
  作者：FABRITSY A.、 VIXERT S.

  DOI：——

  日期：——